Lubben Terry W. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Mar 10, 2022
Insider Transaction Report
Form 4
Lubben Terry W.
SVP, Operations
Transactions
- Purchase
Common Stock
2022-03-08$18.62/sh+2,500$46,550→ 5,850 total - Award
Common Stock
2022-03-08+3,350→ 3,350 total - Award
Stock Option (Right to Buy)
2022-03-08+25,800→ 25,800 totalExercise: $19.15Exp: 2032-03-08→ Common Stock (25,800 underlying)
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F2]Includes 3,350 RSUs.
- [F3]The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $18.347 to $18.65 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.